ロード中...
Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making
Bisphosphonates are first-line therapy for osteoporosis, with alendronate, risedronate, and zoledronate as the main treatments used globally. After one year of therapy, bisphosphonates are retained in bone for extended periods with extended anti-fracture effects after discontinuation. Due to this co...
保存先:
| 出版年: | J Clin Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7963175/ https://ncbi.nlm.nih.gov/pubmed/33803095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051140 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|